Hl Joint100 For Joint And Cartilage

Punica Granatum Fruit, Eucommia Ulmoides Bark, Achyranthes Japonica Root


Hlscience Co.,ltd
Human Otc Drug
NDC 83133-010
Hl Joint100 For Joint And Cartilage also known as Punica Granatum Fruit, Eucommia Ulmoides Bark, Achyranthes Japonica Root is a human otc drug labeled by 'Hlscience Co.,ltd'. National Drug Code (NDC) number for Hl Joint100 For Joint And Cartilage is 83133-010. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Hl Joint100 For Joint And Cartilage drug includes Achyranthes Japonica Root - 50 mg/1 Eucommia Ulmoides Bark - 200 mg/1 Pomegranate - 250 mg/1 . The currest status of Hl Joint100 For Joint And Cartilage drug is Active.

Drug Information:

Drug NDC: 83133-010
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Hl Joint100 For Joint And Cartilage
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Punica Granatum Fruit, Eucommia Ulmoides Bark, Achyranthes Japonica Root
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Hlscience Co.,ltd
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ACHYRANTHES JAPONICA ROOT - 50 mg/1
EUCOMMIA ULMOIDES BARK - 200 mg/1
POMEGRANATE - 250 mg/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Nov, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 04 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:HLSCIENCE CO.,LTD
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:IM19VOE23G
L878N1L0AR
56687D1Z4D
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
83133-010-0110 BLISTER PACK in 1 BOX (83133-010-01) / 6 TABLET in 1 BLISTER PACK01 Nov, 2022N/ANo
83133-010-0220 BLISTER PACK in 1 BOX (83133-010-02) / 6 TABLET in 1 BLISTER PACK01 Nov, 2022N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose strengthen articular cartilage

Product Elements:

Hl joint100 for joint and cartilage punica granatum fruit, eucommia ulmoides bark, achyranthes japonica root pomegranate pomegranate eucommia ulmoides bark eucommia ulmoides bark achyranthes japonica root achyranthes japonica root cholecalciferol zinc oxide manganese sulfate phytonadione

Indications and Usage:

Uses ■ helps strengthen joint and cartilage

Warnings:

Warnings ■ take it with enough water as it might be stuck in throat or cause discomfort when ingested. ■ stop ingestion if you have gastrointestinal problems or indigestion symptoms. ■ if you have any abnormal symptoms according to your physical condition, stop taking it. ■ if there is any abnormality in the product before ingestion, please refrain from ingestion. ■ for specific ingredients of allergic to the constitution, please check the raw ingredients before ingestion. ■ for infants, toddlers, children, pregnant women and lactating women, please be careful about ingestion ■ people sensitive to estrogen hormone, please be careful. ■ consult with an expert if you have hypercalcemia or take medicines ■ in case of any abnormality, stop intake and consult with an expert.

Dosage and Administration:

Directions ■ once a day, take 2 tablets with enough water.

Package Label Principal Display Panel:

Hl joint100 for joint and cartilage 800mg x 60 tablets ndc : 83133-010-01 image of box

Hl joint100 for joint and cartilage 800mg x 120 tablets (front image) ndc : 83133-010-02 image of box

Hl joint100 for joint and cartilage 800mg x 120 tablets (back image) ndc : 83133-010-02 image of box

Further Questions:

Questions [customer satisfaction center] +82-080-313-0001


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.